Process View
Any process that stops, prevents, or reduces the frequency, rate or extent of biomineral tissue development, the formation of hard tissues that consist mainly of inorganic compounds.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of biomineral tissue development"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
CCR5 | chemokine (C-C motif) receptor 5 | 1.000 | Human | |
CCL5 | chemokine (C-C motif) ligand 5 | 0.999 | Human | |
CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.923 | ||
CCL4 | chemokine (C-C motif) ligand 4 | 0.903 | Human | |
CCR7 | chemokine (C-C motif) receptor 7 | 0.750 | Human | |
IFNG | interferon, gamma | 0.625 | ||
IL2RB | interleukin 2 receptor, beta | 0.603 | ||
IL8 | interleukin 8 | 0.498 | ||
CCL2 | chemokine (C-C motif) ligand 2 | 0.424 | Human | |
AXL | AXL receptor tyrosine kinase | 0.377 | ||
CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.277 | Human | |
CCL19 | chemokine (C-C motif) ligand 19 | 0.275 | Human | |
CCR1 | chemokine (C-C motif) receptor 1 | 0.270 | ||
CXCR6 | chemokine (C-X-C motif) receptor 6 | 0.270 | Human | |
CCL22 | chemokine (C-C motif) ligand 22 | 0.269 | Human | |
LTA | lymphotoxin alpha (TNF superfamily, member 1) | 0.238 | ||
CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.238 | ||
CCL8 | chemokine (C-C motif) ligand 8 | 0.232 | Human | |
IL1B | interleukin 1, beta | 0.224 | ||
CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.224 | ||
CXCR3 | chemokine (C-X-C motif) receptor 3 | 0.213 | Human | |
DPP4 | dipeptidyl-peptidase 4 | 0.199 | ||
CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.152 | ||
GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.145 | ||
KDM2B | lysine (K)-specific demethylase 2B | 0.116 | ||
CCR4 | chemokine (C-C motif) receptor 4 | 0.113 | Human | |
CCL7 | chemokine (C-C motif) ligand 7 | 0.113 | Human | |
CCL13 | chemokine (C-C motif) ligand 13 | 0.110 | Human | |
CCR2 | chemokine (C-C motif) receptor 2 | 0.104 | Human | |
CCL3 | chemokine (C-C motif) ligand 3 | 0.098 | ||
IL6 | interleukin 6 (interferon, beta 2) | 0.095 | ||
PCGF1 | polycomb group ring finger 1 | 0.093 | ||
CCL11 | chemokine (C-C motif) ligand 11 | 0.091 | Human | |
CD40LG | CD40 ligand | 0.082 | ||
IRF4 | interferon regulatory factor 4 | 0.069 | ||
CD2 | CD2 molecule | 0.069 | ||
IL2RG | interleukin 2 receptor, gamma | 0.066 | ||
SLAMF7 | SLAM family member 7 | 0.063 | ||
CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.055 | ||
IL16 | interleukin 16 (lymphocyte chemoattractant factor) | 0.053 | ||
CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.048 | ||
RGS1 | regulator of G-protein signaling 1 | 0.047 | ||
IL21R | interleukin 21 receptor | 0.046 | ||
IL7R | interleukin 7 receptor | 0.044 | ||
TNF | tumor necrosis factor | 0.042 | ||
MATK | megakaryocyte-associated tyrosine kinase | 0.041 | ||
ALB | albumin | 0.039 | ||
CXCR5 | chemokine (C-X-C motif) receptor 5 | 0.039 | Human | |
CXCR4 | chemokine (C-X-C motif) receptor 4 | 0.037 | Human | |
CCR3 | chemokine (C-C motif) receptor 3 | 0.035 | Human | |
TAL1 | T-cell acute lymphocytic leukemia 1 | 0.034 | ||
SSX4 | synovial sarcoma, X breakpoint 4 | 0.033 | ||
CCR6 | chemokine (C-C motif) receptor 6 | 0.032 | Human | |
CD83 | CD83 molecule | 0.032 | ||
IL1R2 | interleukin 1 receptor, type II | 0.031 | ||
CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.030 | ||
SELE | selectin E | 0.029 | ||
CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | 0.028 | ||
IDE | insulin-degrading enzyme | 0.026 | ||
CCL21 | chemokine (C-C motif) ligand 21 | 0.024 | ||
CCL20 | chemokine (C-C motif) ligand 20 | 0.024 | Human | |
IL10 | interleukin 10 | 0.023 | ||
RERE | arginine-glutamic acid dipeptide (RE) repeats | 0.023 | ||
ADAMDEC1 | ADAM-like, decysin 1 | 0.021 | ||
TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.020 | ||
MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.020 | ||
CCL1 | chemokine (C-C motif) ligand 1 | 0.020 | Human | |
LTB | lymphotoxin beta (TNF superfamily, member 3) | 0.019 | ||
UBD | ubiquitin D | 0.018 | ||
SOD2 | superoxide dismutase 2, mitochondrial | 0.018 | ||
CLEC7A | C-type lectin domain family 7, member A | 0.018 | ||
LAMP3 | lysosomal-associated membrane protein 3 | 0.018 | ||
GPR171 | G protein-coupled receptor 171 | 0.018 | ||
CCR9 | chemokine (C-C motif) receptor 9 | 0.017 | Human | |
CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.017 | ||
IL1F5 | interleukin 1 family, member 5 (delta) | 0.016 | ||
IL1RN | interleukin 1 receptor antagonist | 0.015 | ||
VCAM1 | vascular cell adhesion molecule 1 | 0.015 | ||
LGALS2 | lectin, galactoside-binding, soluble, 2 | 0.015 | ||
ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.014 | ||
KLRD1 | killer cell lectin-like receptor subfamily D, member 1 | 0.014 | ||
LAIR1 | leukocyte-associated immunoglobulin-like receptor 1 | 0.014 | ||
IL13 | interleukin 13 | 0.014 | ||
IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.013 | ||
CD69 | CD69 molecule | 0.013 | ||
AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.013 | ||
BCL2A1 | BCL2-related protein A1 | 0.013 | ||
AQP9 | aquaporin 9 | 0.013 | ||
RUNX1 | runt-related transcription factor 1 | 0.012 | ||
MSR1 | macrophage scavenger receptor 1 | 0.012 | ||
EBI3 | Epstein-Barr virus induced 3 | 0.012 | ||
IL1A | interleukin 1, alpha | 0.012 | ||
FPR3 | formyl peptide receptor 3 | 0.012 | ||
LAG3 | lymphocyte-activation gene 3 | 0.012 | ||
RNF2 | ring finger protein 2 | 0.011 | ||
USP7 | ubiquitin specific peptidase 7 (herpes virus-associated) | 0.011 | ||
CH25H | cholesterol 25-hydroxylase | 0.011 | ||
IL18RAP | interleukin 18 receptor accessory protein | 0.011 | ||
PLAU | plasminogen activator, urokinase | 0.011 | ||
HLA-DOA | major histocompatibility complex, class II, DO alpha | 0.010 |